Related Experiment Videos

[Cardiac syncope: 4 case reports]

R Candinas1, P Greminger

  • 1Departement für Innere Medizin, Universitätsspital Zürich.

Schweizerische Medizinische Wochenschrift
|June 25, 1994
PubMed

Insights

Syncope, or fainting, can result from various tachycardias. Effective treatments include antiarrhythmic drugs, surgery, cardioverter-defibrillator implantation, and radiofrequency ablation for arrhythmias.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Background:

  • Syncope is a transient loss of consciousness often caused by reduced cerebral blood flow.
  • Tachycardia, a heart rate exceeding 100 beats per minute, can precipitate syncope.
  • Understanding the etiology of syncope is crucial for appropriate management.

Observation:

  • This study details four patients experiencing syncope attributed to tachycardias of diverse origins.
  • Clinical presentations of specific conditions like arrhythmogenic right ventricular dysplasia and Wolff-Parkinson-White syndrome were examined.

Findings:

  • Syncope due to tachycardia necessitates a thorough etiological investigation.
  • Therapeutic strategies encompass antiarrhythmic drug therapy, surgical interventions, and catheter ablation.
  • Implantation of a cardioverter-defibrillator is a key option for managing life-threatening arrhythmias.

Implications:

  • Accurate diagnosis of tachycardia-induced syncope guides prognosis and treatment selection.
  • Programmed ventricular stimulation aids in guiding antiarrhythmic therapy.
  • Advanced interventions like radiofrequency ablation offer curative potential for specific arrhythmias.

Related Concept Videos